期刊: CARDIOVASCULAR RESEARCH, 2022; 118 (5)
Aims The goal of our study was to investigate the heterogeneity of cardiac macrophages (CM phi s) in mice with transverse aortic constriction (TAC) vi......
期刊: CARDIOVASCULAR RESEARCH, 2022; 118 (9)
Aims The heart undergoes pathological remodelling under increased stress and neuronal imbalance. MicroRNAs (miRNAs) are involved in post-transcription......
期刊: CARDIOVASCULAR RESEARCH, 2022; 118 (7)
Aims The clinical use of antitumour agent doxorubicin (DOX) is hampered by its dose-dependent cardiotoxicity. Development of highly efficient and safe......
期刊: CARDIOVASCULAR RESEARCH, 2022; 118 (8)
Aims Recent studies have shown that the choline-derived metabolite trimethylamine N-oxide (TMAO) is a biomarker that promotes cardiovascular disease t......
期刊: CARDIOVASCULAR RESEARCH, 2022; 118 (1)
CD36, also known as the scavenger receptor B2, is a multifunctional receptor widely expressed in various organs. CD36 plays a crucial role in the upta......
期刊: CARDIOVASCULAR RESEARCH, 2022; 118 (3)
Aims Ageing is the most significant contributor to the increasing prevalence of atrial fibrillation (AF). The gut microbiota dysbiosis is involved in ......
期刊: CARDIOVASCULAR RESEARCH, 2022; 118 (9)
Aims Interleukin (IL)-5 mediates the development of eosinophils (EOS) that are essential for tissue post-injury repair. It remains unknown whether IL-......
期刊: CARDIOVASCULAR RESEARCH, 2022; 118 (3)
Aims Congenital heart disease (CHD) frequently occurs in newborns due to abnormal formation of the heart or major blood vessels. Mutations in the GATA......
期刊: CARDIOVASCULAR RESEARCH, 2022; 118 (1)
Vasculopathy is a pathological process occurring in the blood vessel wall, which could affect the haemostasis and physiological functions of all the v......
期刊: CARDIOVASCULAR RESEARCH, 2022; 118 (12)
Aims Remdesivir is a prodrug of an adenosine triphosphate analogue and is currently the only drug formally approved for the treatment of hospitalized ......
期刊: CARDIOVASCULAR RESEARCH, 2022; 118 (13)
Aims Abnormal intracellular calcium (Ca2+) handling contributes to the progressive nature of atrial fibrillation (AF), the most common sustained cardi......
期刊: CARDIOVASCULAR RESEARCH, 2022; 118 (2)
Aims Fibroblast growth factor (FGF) 21, a key regulator of energy metabolism, is currently evaluated in humans for treatment of type 2 diabetes and no......
期刊: CARDIOVASCULAR RESEARCH, 2022; 118 (10)
Aims Concern about the cardiovascular safety of coronavirus disease 2019 (COVID-19) vaccines among individuals with cardiovascular disease (CVD) may l......
期刊: CARDIOVASCULAR RESEARCH, 2022; 118 (3)
Aims Macrophage-mediated inflammatory response represents a key pathophysiological process in a host of cardiovascular diseases including heart failur......
期刊: CARDIOVASCULAR RESEARCH, 2022; 118 (6)
Aims Acute aortic dissection (AAD) is a life-threatening disease with high morbidity and mortality. Previous studies have showed that vascular smooth ......